Procter & Gamble Health Quarterly Results for Trading Insights
PGHL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹234 Cr
QMarch 2025
Procter & Gamble Health Quarterly Results Key Highlights
- Revenue of ₹945 Cr in March 2025 (+0.0% vs March 2025, -19.0% vs March 2024)
- Net Profit of ₹234 Cr in March 2025 (+0.0% vs March 2025, +16.4% vs March 2024)
- EBITDA of ₹329 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 34.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹141.00 in March 2025 (+0.0% vs March 2025)
Procter & Gamble Health Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,301 | 945 | 1,167 | 1,248 | 1,128 | 37.7% | - |
| Net Profit (₹ Cr) | 307 | 234 | 201 | 230 | 193 | - | - |
| EBITDA (₹ Cr) | 431 | 329 | 322 | 343 | 281 | - | - |
| EPS (₹) | 184.80 | 141.00 | 121.00 | 138.00 | 116.00 | - | - |
| Operating Margin (%) | 32.0% | 34.0% | 27.0% | 26.0% | 24.0% | - | - |
Procter & Gamble Health Share Price Trend Around Quarterly Results
Visualize Procter & Gamble Health's 1-year price movement across quarterly results — ideal for logging trades in Procter & Gamble Health share price
chart using Tickjournal. All values in ₹.
Related Pages for Procter & Gamble Health
Additional stock information and data for PGHL
Revenue Trend (₹ Cr)
March 2023
1,248
March 2024
1,167
March 2025
945
2026
1,301
Net Profit Trend (₹ Cr)
March 2023
230
March 2024
201
March 2025
234
2026
307
Operating Margin Trend (%)
March 2023
26.0%
March 2024
27.0%
March 2025
34.0%
2026
32.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Procter & Gamble Health quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores